US Stock MarketDetailed Quotes

XCUR Exicure

Watchlist
  • 0.5001
  • -0.0089-1.75%
Close Apr 26 16:00 ET
4.33MMarket Cap0.28P/E (TTM)

About Exicure Company

Exicure, Inc. develops therapeutics for immuno-oncology, genetic disorders and other indications based on its proprietary Spherical Nucleic Acid. Its product pipeline include Cavrotolimod (AST-008) and XCUR-FXN. The company was founded by Chad A. Mirkin and Colby Shad Thaxton in June 2011 and is headquartered in Skokie, IL.

Company Profile

SymbolXCUR
Company NameExicure
Listing DateJul 31, 2019
Founded2011
CEOMr. Paul Kang
MarketNASDAQ
Employees13
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2430 North Halsted Street
CityChicago
ProvinceIllinois
CountryUnited States of America
Zip Code60614
Phone1-847-673-1700
Websitehttp://www.exicuretx.com

Company Executives

  • Name
  • Position
  • Salary
  • Paul Kang
  • Director, Chief Executive Officer and President
  • --
  • Joshua Miller
  • Chief Accounting Officer
  • --
  • Jiyoung Hwang
  • Director, Chief Financial Officer and Secretary
  • --
  • Minhee Eom
  • Director
  • --
  • Dongho Lee
  • Director
  • --
  • Hyuk Joon Ko
  • Director
  • --
  • Hojoon Lee
  • Director
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg